Macrophage Pharma
Englewood Cliffs
About Macrophage Pharma
Macrophage Pharma is an immuno-oncology company focused on the discovery and development of novel therapies designed to enhance anti-tumour immune responses. The company’s technology platform is designed to deliver small molecule drugs to tumour associated macrophages in a highly selective manner to activate the body’s natural immune system to fight cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $11.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2017)
- Website: macrophagetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Oncology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/macrophage-pharma-119454 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.